NCT00767637View on ClinicalTrials.gov

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
HyperphosphatemiaDialysis
Interventions
DRUG

Lanthanum Carbonate (BAY77-1931)

BAY77-1931 750mg, in the morning, day and evening

Trial Locations (2)

379-2211

Isesaki

683-0002

Yonago

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY